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Cerebral small vessel disease (CSVD) indicates a group of pathological processes acting on the arterioles, capillaries and venules of the brain and resulting in both ischemic and hemorrhagic lesions \[[@b1-ad-10-3-570], [@b2-ad-10-3-570]\]. CSVD is a very common cause of substantial cognitive \[[@b3-ad-10-3-570]\] and psychiatric \[[@b4-ad-10-3-570]\] disabilities in older people, and contributes to 45% of dementias \[[@b5-ad-10-3-570]\].

On brain magnetic resonance imaging (MRI), four closely correlated manifestations including lacunes, cerebral microbleeds (CMBs), white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS) and cortical superficial siderosis (cSS) are markers of CSVD \[[@b2-ad-10-3-570], [@b6-ad-10-3-570], [@b7-ad-10-3-570]\]. However, one patient may present these markers simultaneously \[[@b8-ad-10-3-570]\]. Therefore, the total burden of CSVD might better capture the overall effect of CSVD than only one or two individual markers \[[@b9-ad-10-3-570]\]. Recently, one total CSVD score was proposed \[[@b9-ad-10-3-570]-[@b12-ad-10-3-570]\] to reflect the overall effect of CSVD on the brain.

Primary intracerebral hemorrhage (ICH), which mainly consists of cerebral amyloid angiopathy (CAA) and hypertensive angiopathy (HA)-related ICH \[[@b2-ad-10-3-570]\], is supposedly due to small vessel disease \[[@b13-ad-10-3-570]\]. One longitudinal study enrolling heterogeneous cohorts without specifically focusing on ICH \[[@b14-ad-10-3-570]\] reported that recurrent stroke is associated with severe CSVD. In addition, a recent review and meta-analysis demonstrated that multiple CMBs were associated with high ICH recurrence \[[@b15-ad-10-3-570], [@b16-ad-10-3-570]\]. However, to the best of our knowledge, whether the ICH event influences CSVD progression is unclear. Therefore, in this cross-sectional study, we sought to assess (1) the burden and distribution of individual CSVD markers and (2) compare the total burden of CSVD using the reported CSVD score in those patients with recurrent ICH with the total burden in those with first-ever ICH in the setting of primary ICH.

MATERIALS AND METHODS
=====================

Study population
----------------

A consecutive cohort of ICH patients with MRI brain examination who were admitted to the Department of Neurology or Neurosurgery, West China Hospital, Sichuan University from January 2012 to June 2017 were retrospectively reviewed. Patients were encluded in the present study if they had primary ICH and underwent brain MRI including susceptibility weighted imaging (SWI) sequence during hospitalization. Patients with (1) secondary ICH such as aneurysm, arteriovenous malformation, Moyamoya disease, medication or tumor-related ICH, or hemorrhagic transformation after ischemic stroke; (2) primary intraventricular hemorrhage (IVH); (3) a history of ischemic stroke; or (4) poor image quality were excluded. This study was approved by The Medical Ethics Committee of West China Hospital. Informed consent was obtained from all included patients or next-of-kin.

Data collection
---------------

Demographic information and baseline characteristics including age; sex; time from ICH onset to MRI scan, and comorbid conditions, including history of hypertension, diabetes mellitus, hyperlipidemia, history of ICH, and smoking, were retrieved.

Recurrent ICH was defined according to ICH history from the medical records and by reviewing participant's brain MRI-SWI scan, which was sensitive to old hemorrhage as well as recent hemorrhage. Hematoma location was classified into deep \[i.e., basal ganglia (BG), thalamus, brain stem\], lobar (i.e., cortical-subcortical) or cerebellar. Both old ICHs and new ICHs were calculated in the number of hematomas. Mixed hematomas were defined as follows: deep + lobar, deep + cerebellar, or deep + lobar + cerebellar. Mixed CMBs were defined the same way as mixed hematomas. Bilateral hematomas were defined as hematomas in bilateral hemispheres. Patients ≥55 years of age with strictly lobar ICH involving cortical or cortico-subcortical regions (cerebellar ICH allowed) with or without pure lobar CMBs, but no deep CMBs were coded as cases of cerebral amyloid angiopathy (CAA)-ICH according to the modified Boston criteria\[[@b17-ad-10-3-570]\]. Hypertensive angiopathy (HA)-ICH was defined when patients presented with pure deep ICH with or without deep CMBs but no lobar CMBs\[[@b18-ad-10-3-570], [@b19-ad-10-3-570]\]. Patients ≥55 years of age with both deep and lobar hematoma/CMBs were defined as having mixed etiology-ICH, while those \<55 years of age with lobar ICH with or without deep hematoma/CMBs were defined as having undetermined etiology-ICH.

MRI acquisition
---------------

All included patients underwent brain MRI (median 5.95 days, interquartile range 3.86 to 14.79 days after ICH onset) on a 3T MR scanner (Siemens; matrix size, 256 × 256 pixels). Sequences included fluid-attenuated inversion recovery (FLAIR) \[repetition time (RT) 6000 ms; echo time (ET) 100 ms\]; T1- (RT 1600 ms; ET 8.6 ms); T2-weighted image (RT 4500 ms, ET 105 ms); and SWI (RT 207 ms, ET 20 ms).

Assessment of each CSVD marker
------------------------------

The MRI markers of CSVD were rated in line with STRIVE consensus criteria \[[@b13-ad-10-3-570]\].

We defined lacunes as rounded or ovoid lesions of cerebral spinal fluid signal, that is, hyperintensities on a T2-weighted sequence with corresponding hypointensities with a hyperintense rim on FLAIR, ranging from 3 to 20 mm in diameter\[[@b8-ad-10-3-570], [@b9-ad-10-3-570]\], in bilateral hemispheres.

CMBs were defined as small (\<10 mm in diameter), homogeneous, round lesions with low signal intensity on SWI in bilateral hemispheres and differentiated from mineral depositions and vessel flow voids according to the recent consensus \[[@b9-ad-10-3-570], [@b20-ad-10-3-570], [@b21-ad-10-3-570]\].

Cortical superficial siderosis (cSS), the marker of CAA, was defined as curvilinear residues of chronic blood products following the cortical surface distinct from vessels and was detected as linear hypointensities on SWI \[[@b7-ad-10-3-570], [@b22-ad-10-3-570]\]. The severity of cSS was classified into disseminated (involving \>3 sulci) or focal (≤3 sulci) in line with previous studies \[[@b7-ad-10-3-570], [@b22-ad-10-3-570]\].

WMH were assessed on T2-weighted and FLAIR images in deep and periventricular regions in the ICH-free hemisphere or in the hemisphere with the smaller hematoma when patients had bilateral hematomas. The severity of WMH was rated using the Fazekas scale from 0 to 3 \[[@b20-ad-10-3-570], [@b23-ad-10-3-570]\]. The presence of WMH was defined as deep WMH with a Fazekas score of 2-3 and/or periventricular WMH with a Fazekas score of 3 \[[@b9-ad-10-3-570], [@b14-ad-10-3-570]\]. The sum of the scores for deep and periventricular WMH was considered as the total WMH score \[[@b20-ad-10-3-570]\].

###### 

Clinical and neuroimaging characteristics of the study population.

  ------------------------------------------------------------------------------------------------------------
  Variable                                  All participants\   Recurrent ICH\   First-ever ICH\   *P* Value
                                            (n=184)             (n=45)           (n=139)           
  ----------------------------------------- ------------------- ---------------- ----------------- -----------
  Clinical characteristics                                                                         

  Age, Y, mean (SD)                         61.0 (12.5)         60.8 (10.4)      61.0 (13.1)       0.902

  Sex, male, n (%)                          139 (75.5)          30 (66.7)        109 (78.4)        0.111

  History of hypertension, n (%)            122 (66.3)          34 (75.6)        88 (63.3)         0.131

  History of DM, n (%)                      17 (9.2)            2 (4.4)          15 (10.8)         0.250

  History of hyperlipidemia, n (%)          6 (3.3)             3 (6.7)          3 (2.2)           0.158

  Smoking, n (%)                            61 (33.2)           10 (22.2)        51 (36.7)         0.073

  ICH etiology                                                                                     

   CAA-ICH, n (%)                           26 (14.1)           5 (11.1)         21 (15.1)         0.066

   HA-ICH, n (%)                            75 (40.8)           13 (28.9)        62 (44.6)         

   Mixed etiology-ICH, n (%)                57 (31.0)           21 (46.7)        36 (25.9)         

   Undetermined, n (%)                      26 (14.1)           6 (13.3)         20 (14.4)         

  Neuroimaging characteristics                                                                     

  ICH location,                                                                                    

   Deep, n (%)                              128 (69.6)          28 (62.2)        100 (71.9)        0.177

   Lobar, n (%)                             48 (26.1)           13 (28.9)        35 (25.2)         

   Cerebellum, n (%)                        8 (4.3)             4 (8.9)          4 (2.9)           

  Presence of lacunes, n (%)                83 (45.1)           26 (57.8)        57 (41.0)         0.049

  Presence of WMH, n (%)                    90 (48.9)           33 (73.3)        57 (41.0)         \<0.0001

  The severity of WMH                                                                              

   Total WMH 0-2, n (%)                     81 (44.0)           10 (22.2)        71 (51.1)         0.002

   Total WMH 3-4, n (%)                     50 (27.2)           15 (33.3)        35 (25.2)         

   Total WMH 5-6, n (%)                     53 (28.8)           20 (44.4)        33 (23.7)         

  Presence of CMBs, n (%)                   135 (73.4)          40 (88.9)        95 (68.3)         0.007

  The severity of CMBs,                                                                            

   0, n (%)                                 49 (26.6)           5 (11.1)         44 (31.7)         0.014

   1-4, n (%)                               63 (34.2)           16 (35.6)        47 (33.8)         

   ≥5, n (%)                                72 (39.1)           24 (53.3)        48 (34.5)         

  Strictly deep CMBs, n (%)                 45 (24.5)           11 (24.4)        34 (24.5)         0.998

  Strictly lobar CMBs, n (%)                27 (14.7)           7 (15.6)         20 (14.4)         0.848

  Mixed location CMBs, n (%)                63 (34.2)           22 (48.9)        41 (29.5)         0.017

  The presence of cSS, n (%)                44 (23.9)           14 (31.1)        30 (21.6)         0.193

  The presence of disseminated cSS, n (%)   20 (10.9)           6 (13.3)         14 (10.1)         0.584

  Presence of EPVS\>10 in BG, n (%)         92 (50.0)           23 (51.1)        69 (49.6)         0.864

  The severity of EPVS in BG                                                                       

   ≤10, n (%)                               92 (50.0)           22 (48.9)        70 (50.4)         0.686

   11-20, n (%)                             49 (26.6)           14 (31.1)        35 (25.2)         

   \>20, n (%)                              43 (23.4)           9 (20.0)         34 (24.5)         

  The severity of EPVS in CSO                                                                      

   ≤10, n (%)                               78 (42.4)           15 (33.3)        63 (45.3)         0.069

   11-20, n (%)                             46 (25.00           9 (20.0)         37 (26.6)         

   \>20, n (%)                              60 (32.6)           21 (46.7)        39 (28.1)         

  CSVD score, median (IQR)                  2 (1-3)             3 (2-4)          2 (1-3)           0.002
  ------------------------------------------------------------------------------------------------------------

Abbreviation: ICH, intracerebral hemorrhage; DM, diabetes mellitus; CAA, cerebral amyloid angiopathy; HA, hypertensive angiopathy; CSVD, cerebral small vessel disease; CMBs, cerebral microbleeds; WMH, white matter hyperintensity; cSS, cortical superficial siderosis; EPVS, enlarged perivascular spaces; CSO, centrum semiovale; BG, basal ganglia; SD, standard deviation; IQR, interquartile range.

EPVS were defined as \<3 mm punctate or linear hyperintensities on a T2-weighted sequence with corresponding hypointensities on a T1/FLAIR sequence \[[@b9-ad-10-3-570], [@b20-ad-10-3-570]\]. EPVS were rated in the centrum semiovale (CSO) and BG in the ICH-free hemisphere or in the hemisphere with the smaller hematoma when patients had bilateral hematomas. The number of EPVS referred to EPVS in the slice and side with the greatest extent of EPVS after review of all relevant slices of BG or CSO \[[@b24-ad-10-3-570]\].

Determining the overall burden of CSVD
--------------------------------------

Based on the recently proposed CSVD score \[[@b9-ad-10-3-570]\], we assessed the total burden of CSVD on an ordinal scale ranging from 0 to 4 by allocating 1 point to each of the following: the presence of any lacune, any CMB, the presence of WMH, and the number of BG EPVS\>10.

All CSVD markers and hematoma characteristics were assessed by two certified and experienced neurologists (M.X. and Y.C.) blinded to clinical information. Interrater agreement for the identification of CSVD makers and hematoma characteristics was good and even excellent with kappa ranged from 0.643 to 1.000. Kappa values of each imaging variable are shown in [supplementary Table 1](#s1-ad-10-1-570){ref-type="supplementary-material"}.

Statistical analysis
--------------------

Patients were divided into two groups based on the presence or absence of recurrent ICH. We compared the clinical information and imaging characteristics using Student t test or Mann-Whitney U test for continuous data, andχ^2^ test or Fisher exact test for categorical data when appropriate. Multivariate ordinal regression analysis with CSVD score as the dependent variable was performed to assess the association with the presence of recurrent ICH, ≥2 hematomas, mixed hematomas, and bilateral hematomas separately, by adjusting for age, sex, and risk factors (history of hypertension, diabetes mellitus, hyperlipidemia and smoking, which are frequently reported to be associated with individual CSVD markers \[[@b14-ad-10-3-570]\]). Interrater reliability of neuroimaging variable was tested using the kappa statistic. All analyses were performed using SPSS software (version 21; IBM, New York, NY).

RESULTS
=======

Population
----------

A total of 301 ICH participants with MRI-SWI were admitted to our center from January 2012 through June 2017. We excluded 101subjects with secondary causes, 8 with primary IVH, 7 with the history of ischemic stroke and 1 due to poor image quality. Thus, 184 participants with a diagnosis of primary ICH were included in the analysis ([Fig. 1](#F1-ad-10-3-570){ref-type="fig"}).

Of the included participants, their mean age was 61.0 years, and 75.5% were men. Overall, 26 (14.1%) had CAA-ICH, 75 (40.8%) had HA-ICH, 57 (31.0%) had mixed etiology-ICH and 26 (14.1%) had undetermined etiology-ICH. Recurrent ICH was identified in 45 (24.5%) participants. The clinical and neuroimaging characteristics of all included participants, and the subgroups with recurrent ICH and first-ever ICH are summarized in [Table 1](#T1-ad-10-3-570){ref-type="table"}. There were no significant differences among the two groups with regard to demographic characteristics, comorbid conditions, ICH etiology, or ICH location.

Figure 1.Flow gram of patient selection.

Patients with CAA-ICH had a higher incidence of recurrence than those with HA-ICH \[19.2% (5/26) versus (vs) 17.3% (13/75)\] without reaching statistical significance. In contrast, patients with mixed etiology-ICH were more likely to have recurrent ICH than those with CAA- or HA-ICH (36.8% vs 17.8%, *p*=0.008, Pearson χ^2^ test). [Supplementary Table 2](#s1-ad-10-1-570){ref-type="supplementary-material"} shows the severity of WMH by ICH etiology; the data show that there was a significant difference among patients with HA-, CAA-, and mixed etiology- ICH with regard to the presence of WMH (P\<0.00000001), the presence of deep WMH with a score of 2-3 (P\<0.0000001), and the presence of periventricular WMH with a score of 3 (P\<0.00001). The presence of WMH, deep WMH with a score of 2-3 and periventricular WMH with a score of 3 was the highest in patients with mixed etiology-ICH, followed by those with CAA-ICH and HA-ICH.

###### 

Total CSVD score for patients with recurrent ICH and first-ever ICH.

  CSVD score   All participants (n=184)   Recurrent ICH (n=45)   First-ever ICH (n=139)
  ------------ -------------------------- ---------------------- ------------------------
  0, n (%)     25 (13.6)                  2 (4.4)                23 (16.5)
  1, n (%)     36 (19.6)                  8 (17.8)               28 (20.1)
  2, n (%)     41 (22.3)                  8 (17.8)               33 (23.7)
  3, n (%)     46 (25.0)                  10 (22.2)              36 (25.9)
  4, n (%)     36 (19.6)                  17 (37.8)              19 (13.7)

Abbreviation: CSVD, cerebral small vessel disease; ICH, intracerebral hemorrhage

Overall, 48 (26.1%) patients had ≥2 hematomas and 11 (6.0%) had ≥3 hematomas among the 184 participants. Of those with ≥2 hematomas, 93.8% (45/48) exhibited recurrent ICH, 4.2% (2/48) exhibited first-ever ICH with multiple hematomas, and 2.1% (1/48) had two ICH events located in the same region. In contrast, all of the 11 participants with ≥3 hematomas had recurrent ICH. Mixed hematomas were identified in 16 (8.7%) participants. Of these, the most prevalent type was deep + lobar (68.8%, 11/16), followed by deep + cerebellar (18.8%, 3/16) and deep + lobar + cerebellar (12.5%, 2/16). Bilateral hematomas were found in 33 (17.9%, 33/184) participants. All of the patients with either mixed hematomas or bilateral hematomas exhibited recurrent ICH.

Figure 2.Hematoma characteristics and CSVD score. **A**) the presence of recurrent ICH and CSVD score. **B**) The number of hematomas and CSVD score. **C**) the presence of mixed hematomas and CSVD score. **D**) the presence of bilateral hematomas and CSVD score.

Association between ICH characteristics and total CSVD score
------------------------------------------------------------

Of the four CSVD markers, recurrent ICH was more often found in patients with lacunes (*p*=0.049), WMH (*p*\<0.0001), and CMBs (*p*=0.007) ([Table 1](#T1-ad-10-3-570){ref-type="table"}). As expected, recurrent ICH was associated with a higher CSVD score than first-ever ICH \[[Table 1](#T1-ad-10-3-570){ref-type="table"}, *p*=0.002 (Mann-Whitney test); [Table 2](#T2-ad-10-3-570){ref-type="table"}, *p*=0.006 (Pearson χ^2^ test)\] ([Fig. 2A](#F2-ad-10-3-570){ref-type="fig"}), mainly due to the higher prevalence of lacunes, WMH, and CMBs in the former. Meanwhile, the presence of recurrent ICH was significantly associated with an increasing burden of WMH (*p*=0.002), especially those with WMH with a score of 5-6. Similarly, recurrent ICH correlated with a high burden of CMBs (*p*=0.014). When stratifying participants by CMB location, recurrent ICH correlated with a high incidence of mixed CMBs (*p*=0.017), while strictly deep CMBs and strictly lobar CMBs did not differ between patients with recurrent ICH and first-ever ICH. For cSS and EPVS, there were no significant differences between recurrent and first-ever ICH with regard to the presence of cSS, the presence of disseminated cSS, BG EPVS\>10, and the severity of BG EPVS and CSO EPVS.

In univariate analysis, the presence of recurrent ICH (*p*=0.001), ≥2 hematomas (*p*=0.001), mixed hematomas (*p*\<0.00001), and bilateral hematomas (*p*=0.003) were all separately significantly associated with an increased CSVD burden ([Table 3](#T3-ad-10-3-570){ref-type="table"}, [Fig. 2 A-D](#F2-ad-10-3-570){ref-type="fig"}). After fully adjusting for sex, age, history of hypertension, diabetes mellitus, hyperlipidemia, and smoking, the associations with the presence of recurrent ICH (*p*=0.001), ≥2 hematomas (*p*=0.002), mixed hematomas (*p*\<0.00001), and bilateral hematomas (*p*=0.002) were still significant, especially the association with mixed hematoma.

DISCUSSION
----------

In the present study, we first showed that patients with mixed etiology-ICH more often had recurrent ICH than patients with CAA- or HA-ICH. In addition, we found that patients with recurrent ICH had a higher CSVD score than those with first-ever ICH, mainly due to a higher prevalence of lacunes, WMH, and CMBs in the former. Additionally, we reported that the presence of ≥2 hematomas, mixed hematomas, and bilateral hematomas were separately associated with a higher CSVD score.

Consistent with previous study \[[@b15-ad-10-3-570]\], our data showed that patients with recurrent ICH were more likely to have CMBs and more severe CMBs than those with first-ever ICH. In the past year, the presence of high-grade WMH was also demonstrated to be correlated with stroke recurrence presenting as ICH, atherothrombotic infarctions, and lacunar infarctions in stroke patients \[[@b25-ad-10-3-570]\], which we confirmed in our cohort with a specific focus on primary ICH. However, all former research focused on individual CSVD markers in MRI scans without evaluating the combination of markers as one disease \[[@b6-ad-10-3-570]\] in the setting of primary ICH. Therefore, we compared the association of total burden of CSVD by combining the four markers in recurrent ICH versus that in first-ever ICH.

###### 

Association between ICH and total burden of CSVD in ordinal regression analysis.

  Variable              Unadjusted                           Age- + sex-adjusted                   Fully adjusted           
  --------------------- ------------------------ ----------- ------------------------ ------------ ------------------------ -----------
                        OR (95% CI)              *p*         OR (95% CI)              *p*          OR (95% CI)              *p*
  Recurrent ICH         0.361 (0.195 to 0.668)   0.001       0.313 (0.167 to 0.587)   \<0.001      0.332 (0.174 to 0.632)   0.001
  ≥2 hematomas          0.375 (0.206 to 0.685)   0.001       0.334 (0.181 to 0.616)   \<0.001      0.365 (0.195 to 0.683)   0.002
  Mixed hematomas       0.093 (0.034 to 0.258)   \<0.00001   0.064 (0.022 to 0.187)   \<0.000001   0.073 (0.024 to 0.216)   \<0.00001
  Bilateral hematomas   0.354 (0.178 to 0.705)   0.003       0.288 (0.142 to 0.582)   0.001        0.322 (0.156 to 0.664)   0.002

Fully adjusted: age, sex, history of hypertension, diabetes mellitus, hyperlipidemia, and smoking Abbreviation: CSVD, cerebral small vessel disease; ICH, intracerebral hemorrhage; OR, odds ratio; CI, confidence interval

When focusing on the severity of WMH and ICH etiology, we found that mixed etiology-ICH had the highest proportion of patients exhibiting WMH, deep WMH with a score of 2-3, and periventricular WMH with a score of 3, followed by CAA-ICH and HA-ICH. Our results were in line with those in a previous study \[[@b26-ad-10-3-570]\] that showed that patients with mixed ICH had the highest WMH volume when compared to those with HA-ICH and CAA-ICH.

Meanwhile, participants with ≥2 hematomas, mixed hematomas, and bilateral hematomas were also shown to have a higher CSVD score than those with one hematoma, non-mixed hematomas, and unilateral hematoma, respectively. The above associations were based on the association of recurrent ICH and total burden of CSVD, since recurrent ICH occurred in 93.9% among those with ≥2 hematomas, and all patients with mixed hematomas and bilateral hematomas exhibited recurring ICHs.

However, our study had several limitations. First, in the present study, 10 participants had bilateral BG hematoma, resulting in no hematoma-free BG to rate EPVS and periventricular WMH; thus, BG EPVS and periventricular WMH in the 10 patients were rated in the hemisphere with the smaller hematoma, potentially resulting in detection bias in the 10 participants. However, after excluding the 10 participants, the association of CSVD score with the presence of recurrent ICH (*p*=0.001), ≥2 hematomas (*p*=0.001), mixed hematomas (*p*\<0.0001), and bilateral hematomas (*p*=0.001) separately still remained significant after fully adjusting. Second, not all ICH patients received MRI scans. Patients who were too sick, had contraindications of MRI examination, refused to undergo MRI, or those family members refused to allow MRI were excluded. In the study period, ICH in 1033 patients with CTA or DSA examination and without MRI (including SWI sequence) might be caused by HA or CAA. Data showed that those patients were younger and more likely to have hypertension. Furthermore, the condition of those patients was more severe (lower GCS and higher NIHSS) than the condition of the patients with SWI examination (see [supplementary Table 3](#s1-ad-10-1-570){ref-type="supplementary-material"}). However, there were not significant differences in hematoma location in patients with and without MRI. Thus, the results in this present study need to be interpreted with caution, because brain MRI was performed in patients with less severe hemorrhagic severity. Third, the sample size in our study was small; therefore, the findings shown in this study need to be confirmed in future larger well-designed studies. Finally, the definition of recurrent ICH was based on index presentation and brain MRI characteristics but not on a follow-up period; thus, future follow-up studies investigating baseline CSVD burden and follow-up CSVD burden after ICH (i.e., one year after ICH onset among survival patients) are warranted to confirm these results.

Conclusion
==========

This study demonstrated that recurrent ICH occurred mostly among patients with mixed etiology and was associated with a higher CSVD burden than first-ever ICH. Additionally, the presence of ≥2 hematomas, mixed hematomas, and bilateral hematomas were separately correlated with a higher CSVD score. Future large studies are warranted to confirm our results.

Supplemental data
=================

Supplemental data are available at [www.aginganddisease.org/EN/10.14336/AD.2017.0804](http://www.aginganddisease.org/EN/10.14336/AD.2017.0804).
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